Follow The Filings

CJMB Callan JMB

Callan JMB earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CJMB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CJMB insider trades
  • $166K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Gerald Dial Director
    Buy
    $7,620 10,000 shares at $0.7600 +500% to stake
    Traded Dec 30, 2025 Filed Jun 1
  2. David J Croyle Chief Medical Officer
    Buy
    $18K 10,195 shares at $1.75 +1.3% to stake
    Traded Mar 20 Filed Mar 26
  3. David J Croyle Chief Medical Officer
    Buy
    $26K 14,805 shares at $1.76 +1.9% to stake
    Traded Mar 6 Filed Mar 10
  4. Gerald Dial Director
    Buy
    $2,409 2,000 shares at $1.20 New stake
    Traded Dec 30, 2025 Filed Jan 6
  5. Wayne D Williams CEO
    Buy
    $8,650 5,000 shares at $1.73 +6.3% to stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
  6. Wayne D Williams CEO
    Buy
    $27K 15,798 shares at $1.72
    Traded Dec 11–15 Filed Dec 15, 2025
  7. Wayne D Williams CEO
    Buy
    $73K 44,545 shares at $1.65 +186% to stake
    Traded Dec 10–11 Filed Dec 12, 2025
  8. Liberty Smith Duke Director
    Buy
    $2,334 1,512 shares at $1.54 New stake
    Traded Dec 8–9 Filed Dec 10, 2025

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,9.01
8-K 3.01,9.01
8-K 5.02,9.01
8-K 1.01,9.01
8-K 1.01,3.02,9.01
8-K 1.01,3.02,9.01
10-Q
8-K 3.01
8-K 5.02,9.01
8-K 1.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 3.01
8-K 2.02,9.01
10-K
8-K 1.01,9.01
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 5.07
DEF 14A
8-K 8.01,9.01
8-K 5.02,9.01
8-K 2.02,9.01
10-Q
424B3

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.